AG-1296

N/A

Report date: 2022/08/24 20:00:31

NME

Base Information

Drug NameAG-1296

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein-tyrosine kinases inhibitorsStem cell growth factor receptor inhibitorsPlatelet-derived growth factor receptor inhibitors +[4]

TargetsStem cell growth factor receptorTyrosine-protein kinase receptor FLT3Protein-tyrosine kinases +[4]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesFriedrich Schiller University Jena

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesFriedrich Schiller University Jena

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A